Aitken J, Ambrose K, Barrell S, Beale R, Bineva-Todd G, Biswas D, Byrne R, Caidan S, Cherepanov P, Churchward L, Clark G, Crawford M, Cubitt L, Dearing V, Earl C, Edwards A, Ekin C, Fidanis E, Gaiba A, Gamblin S, Gandhi S, Goldman J, Goldstone R, Grant P, Greco M, Heaney J, Hindmarsh S, Houlihan C, Howell M, Hubank M, Hughes D, Instrell R, Jackson D, Jamal-Hanjani M, Jiang M, Johnson M, Jones L, Kanu N, Kassiotis G, Kirk S, Kjaer S, Levett A, Levett L, Levi M, Lu W, MacRae J, Matthews J, McCoy L, Moore C, Moore D, Nastouli E, Nicod J, Nightingale L, Olsen J, O’Reilly N, Pabari A, Papayannopoulos V, Patel N, Peat N, Pollitt M, Ratcliffe P, Reis e Sousa C, Rosa A, Rosenthal R, Roustan C, Rowan A, Shin G, Snell D, Song O, Spyer M, Strange A, Swanton C, Turner J, Turner M, Wack A, Walker P, Ward S, Wong W, Wright J, Wu M. Scalable and robust SARS-CoV-2 testing in an academic center. Nature Biotechnology 2020, 38: 927-931. PMID: 32555528, DOI: 10.1038/s41587-020-0588-y.Peer-Reviewed Original Research